Insulin signaling and pharmacology in humans and in corals

PeerJ. 2024 Jan 31:12:e16804. doi: 10.7717/peerj.16804. eCollection 2024.

Abstract

Once thought to be a unique capability of the Langerhans islets in the pancreas of mammals, insulin (INS) signaling is now recognized as an evolutionarily ancient function going back to prokaryotes. INS is ubiquitously present not only in humans but also in unicellular eukaryotes, fungi, worms, and Drosophila. Remote homologue identification also supports the presence of INS and INS receptor in corals where the availability of glucose is largely dependent on the photosynthetic activity of the symbiotic algae. The cnidarian animal host of corals operates together with a 20,000-sized microbiome, in direct analogy to the human gut microbiome. In humans, aberrant INS signaling is the hallmark of metabolic disease, and is thought to play a major role in aging, and age-related diseases, such as Alzheimer's disease. We here would like to argue that a broader view of INS beyond its human homeostasis function may help us understand other organisms, and in turn, studying those non-model organisms may enable a novel view of the human INS signaling system. To this end, we here review INS signaling from a new angle, by drawing analogies between humans and corals at the molecular level.

Keywords: Evolution; Metabolism; Non-model organisms; Signal transduction; Structural biology; Systems biology.

MeSH terms

  • Animals
  • Anthozoa* / metabolism
  • Humans
  • Insulin / metabolism
  • Islets of Langerhans* / metabolism
  • Pancreas / metabolism
  • Signal Transduction

Substances

  • Insulin

Grants and funding

This work was sponsored by NSF grants HDR: DIRSE-IL OAC-1940169, OAC-1939263, OAC-1939699, OAC-1939795, OAC-1939249, and RAPID 2031614. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.